NVST
Envista Holdings Corp
NYSE: NVST · HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES
$24.20
+1.01% today
Updated 2026-06-05
Market cap
$4.00B
P/E ratio
60.00
P/S ratio
1.43x
EPS (TTM)
$0.41
Dividend yield
—
52W range
$18 – $30
Volume
3.1M
WallStSmart proprietary scores
54
out of 100
Grade: C
Hold
Investment rating
6.7
Growth
B6.0
Quality
B5.0
Profitability
C+4.0
Valuation
C5/9
Piotroski F-Score
Moderate
1.5
Altman Z-Score
Distress
—
Industry rank
—
View all highly rated stocks (75+) →202 stocks currently score above 75
Price targets
Analyst target
$29.69
+22.69%
12-Month target
$13.10
-45.87%
Intrinsic (DCF)
—
Margin of safety
—
1 Strong Buy6 Buy8 Hold0 Sell0 Strong Sell
Price chart
Stock snapshot
Strengths
+ Revenue growth 14.40% QoQ
Risks
- Altman Z 1.47 — distress zone
- Thin margins at 2.41%
- Negative free cash flow $-15.80M
- P/E 60.00x — expensive valuation
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $2.57B | $2.57B | $2.51B | $2.72B | $2.81B |
| Net income | $243.10M | $-100.20M | $-1.12B | $47.00M | $38.70M |
| EPS | — | — | — | — | $0.41 |
| Free cash flow | $107.00M | $217.50M | $302.70M | $230.40M | $-15.80M |
| Profit margin | 9.46% | -3.90% | -44.56% | 1.73% | 2.41% |
Peer comparison
Smart narrative
Envista Holdings Corp trades at $24.20. representing a P/E of 60.00x trailing earnings. Our Smart Value Score of 54/100 indicates the stock is fair. The company scores 5/9 on the Piotroski F-Score. With an Altman Z-Score of 1.47, it sits in the distress. TTM revenue stands at $2.81B. with profit margins at 2.41%.
Frequently asked questions
What is Envista Holdings Corp's stock price?
Envista Holdings Corp (NVST) trades at $24.20, on a P/E of 60.0x and a P/S of 1.4x. Those multiples show what the market is paying for each dollar of earnings and sales, which is the real starting point for judging whether the price is reasonable.
Is Envista Holdings Corp overvalued?
Envista Holdings Corp carries a Smart Value Score of 54/100 (Grade C), which we rate Hold. That score blends growth, quality, and valuation into one read.
What is the price target of Envista Holdings Corp (NVST)?
The 12-month analyst consensus target is $29.69, about 22.7% above the current $24.20. A consensus target is the average of Wall Street's 12-month forecasts, so it works as a sentiment gauge rather than a guarantee, and it resets with every earnings cycle.
What is Envista Holdings Corp's revenue?
Envista Holdings Corp's trailing twelve-month revenue is $2.81B. Revenue scale anchors the valuation multiples and shows whether growth is reaching the top line, so it is best read alongside margin and growth trends to see if that revenue is getting more profitable over time.
Altman Z-Score?
Envista Holdings Corp's Altman Z-Score is 1.47, which places it in the distress. The Altman Z-Score gauges bankruptcy risk from profitability, leverage, and asset efficiency, and a higher reading points to lower financial distress risk.
Company info
SectorHEALTHCARE
IndustryMEDICAL INSTRUMENTS & SUPPLIES
CountryUSA
ExchangeNYSE
CurrencyUSD
Quick metrics
P/S ratio1.43x
ROE2.20%
Beta0.89
50D MA$25.08
200D MA$23.38
Shares out0.16B
Float0.16B
Short ratio—
Avg volume3.1M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—